newsfilter
← Latest News
PR Newswire·

Seneca Biopharma Reports Receipt of Warrant Exercise Proceeds

Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need,...